Insiders Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 08:59:34 15/05/2024 pm IST			5-day change	1st Jan Change
3.54 ^SEK	-1.23%		-1.94%	-5.30%

17/04	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
10/04	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Cantargia AB Promotes David Liberg to Chief Scientific Officer	01/23/01	CI
Cantargia : The nomination committees statement	24/23/24	PU
Cantargia Appoints Patrik Renblad as Chief Financial Officer	01/23/01	CI
Cantargia AB Announces Nomination Committee Appointments	21/22/21	CI
Nomination Committee appointed ahead of 2023 Annual General Meeting	21/22/21	AQ
Cantargia AB Announces Executive Changes	08/22/08	CI
Cantargia AB Strengthens Executive Management in Preparation for Late-Stage Clinical Development	10/22/10	CI
(R) Nomination Committee appointed ahead of 2022 Annual General Meeting	29/21/29	PU
Nomination Committee appointed ahead of 2022 Annual General Meeting	29/21/29	AQ
Cantargia AB Announces Appointment of Nomination Committee	29/21/29	CI
Cantargia AB Elect Magnus Nilsson and Damian Marron as New Board Members	26/21/26	CI
Cantargia AB Announces Claus Asbjørn Andersson Declined Re-Election	27/21/27	CI
Cantargia : Changes to Cantargia’s nomination committee	21/20/21	PU
Cantargia : Changes to Cantargia's nomination committee	21/20/21	AQ
Cantargia AB Announces Nomination Committee Changes	21/20/21	CI
Cantargia AB Announces Executive Changes	20/20/20	CI
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20/20/20	PU
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20/20/20	AQ
Cantargia : Cantargia’s nomination committee proposes a new board member	21/20/21	PU
Cantargia : nomination committee proposes a new board member	21/20/21	AQ

No results for this search